洞察市场格局
解锁药品研发情报

免费客服电话

18983288589
试用企业版

【ChiCTR2400092811】Personalised Lifestyle Medicine in Mid-life Project

基本信息
登记号

ChiCTR2400092811

试验状态

正在进行

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2024-11-25

临床申请受理号

/

靶点

/

适应症

Chronic diseases

试验通俗题目

Personalised Lifestyle Medicine in Mid-life Project

试验专业题目

Personalised Lifestyle Medicine in Mid-life Project

申办单位信息
申请人联系人
申请人名称
联系人邮箱
联系人邮编

联系人通讯地址
临床试验信息
试验目的

The specific objectives are: 1. Assessing the undiagnosed hypertension and diabetes mellites (DM) prevalence among those aged 35-59 of the Hong Kong population. 2. Using a cohort approach, to provide intervention to at-risk subjects and change their lifestyle behaviour and biometric measures in short term (6 months). 3. Establish a cohort with longer follow up time (10 years) to facilitate the development of a Hong Kong adapted prediction model of cardiovascular disease (CVD). 4. Assessing the cost-effectiveness of the intervention.

试验分类
试验类型

单臂

试验分期

其它

随机化

Not necessary

盲法

/

试验项目经费来源

The Hong Kong Jockey Club Charities Trust

试验范围

/

目标入组人数

20000

实际入组人数

/

第一例入组时间

2022-02-14

试验终止时间

2025-06-30

是否属于一致性

/

入选标准

1) Aged between 35 – 59. 2) Without doctor-diagnosed chronic diseases and require medication (including diabetes, hypertension, cardiovascular diseases, chronic obstructive pulmonary diseases, depression, autoimmune diseases, and cancer). 3) Not in the waiting list for follow-up healthcare services in the public or private sector because of the listed chronic diseases above.;

排除标准

1) Those who cannot provide consent. 2) Pregnant women. 3) Do not understand Cantonese.;

研究者信息
研究负责人姓名
试验机构

JC School of Public Health and Primary Care, CUHK

研究负责人电话
研究负责人邮箱
研究负责人邮编

/

联系人通讯地址
<END>

最新临床资讯

对摩熵医药数据库感兴趣,可以免费体验产品